G6 Materials Proposes Share Consolidation

NEWS 86

06/27/2023

TSX-V: GGG, OTCQB: GPHBF

The Company’s Proposed Share Consolidation Would Result in the Number of Issued and Outstanding Shares Being Changed from 163,679,193 Pre-Consolidation Shares to Approximately 16,367,919 Post-Consolidation Shares

Ronkonkoma, New York, USA – TheNewswire – June 26, 2023 – G6 Materials Corp. (“G6” or the “Company”) (TSXV: GGG, OTCQB: GPHBF),

a high-tech company with expertise in advanced materials and developing innovative composites for a wide range of industrial uses, announces that it will seek TSX Venture Exchange (“TSX-V”) approval to consolidate all of its issued and outstanding common shares (the “Shares”) on a basis of one (1) post-Consolidation Share for every ten (10) pre-Consolidation Shares (the “Consolidation”). In accordance with current TSX-V policies, shareholder approval will not be required for the proposed Consolidation. The proposed Consolidation has been approved by the Company’s board of directors.

The proposed Consolidation would result in the number of issued and outstanding Shares being reduced from 163,679,193 pre-Consolidation Shares to approximately 16,367,919 post-Consolidation Shares. The effective date of the proposed Consolidation will be disclosed in a subsequent news release.

The Company does not intend to change its name or its current trading symbol in connection with the proposed Consolidation. Management of the Company believe that the proposed Consolidation will better position the Company to raise the funds it requires to finance ongoing business activities.

About G6 Materials Corp.

G6 Materials Corp. is a high-tech company with expertise in advanced materials that creates value developing innovative composites for a wide range of industrial uses. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high-performance composites, and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. has entered the global air filtration market with Breathe⁺, a line of medical-grade HEPA air filtration products enhanced with advanced performance graphene material.

G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprising five granted patents. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility equipped with advanced analytical and material processing equipment.

The Company’s e-commerce websites are listed below:

Breathe⁺: Medical-grade HEPA air filtration enhanced with advanced performance graphene material, for more information, visit breatheplus.tech
Conductive Epoxies: Adhesive materials distributed under the G6-Epoxy^TMtrade name and can be purchased at g6-epoxy.com
R&D Materials: Graphene Laboratories Inc. currently offers over 100 graphene and related products available at graphene-supermarket.com

Forward-Looking Information

This news release contains forward-looking statements within the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes but is not limited to information about the graphene-enhanced air purifier (including efficacy, potential commercialization and patent pending thereof); information about the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.

The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

Risk factors that could cause actual results to differ materially include, but are not limited to, the risk that actual results in commercial applications of the graphene-enhanced air purifier may differ significantly from the Test Results; the Test Results may not be accepted by applicable regulatory agencies required to approve commercialization of the graphene-enhanced air purifier; the Company may not receive required approvals from regulatory agencies to commercialize the graphene-enhanced air purifier; the Company may not achieve further stages of commercialization of the graphene-enhanced air purifier as anticipated, or at all; the Company patent pending (US20210346831A1) may not be granted; the Company may not achieve anticipated commercial gains or profitability from the sale of Breathe⁺Pro Advanced Antimicrobial Graphene Air Filtration System as currently anticipated, or at all; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; competition; dilution; and the volatility of our common share price and volume.

The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Commercial Inquiries

Daniel Stolyarov, President, CTO & Co-CEO

Telephone: (631) 405-5113

Email: [email protected]

Investor Inquiries

Nick Kuzyk, Investor Relations

Telephone: 1-(866)-324-4244

Email: [email protected]

ON BEHALF OF THE BOARD: Daniel Stolyarov, President, CTO & Co-CEO

For more information on G6 Materials Corp., please visit www.G6-Materials.com or its profile page on SEDAR at www.sedar.com.

SOURCE: G6 Materials Corp.